160 related articles for article (PubMed ID: 8807569)
1. 1,25-dihydroxyvitamin D3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats.
Denda M; Finch J; Brown AJ; Nishii Y; Kubodera N; Slatopolsky E
Kidney Int; 1996 Jul; 50(1):34-9. PubMed ID: 8807569
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
[TBL] [Abstract][Full Text] [Related]
3. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content.
Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E
Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408
[TBL] [Abstract][Full Text] [Related]
4. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands.
Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E
Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats.
Shiizaki K; Negi S; Hatamura I; Sakaguchi T; Saji F; Kunimoto K; Mizobuchi M; Imazeki I; Ooshima A; Akizawa T
J Am Soc Nephrol; 2005 Jan; 16(1):97-108. PubMed ID: 15574509
[TBL] [Abstract][Full Text] [Related]
6. Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats.
Slatopolsky E; Finch J; Ritter C; Takahashi F
Am J Kidney Dis; 1998 Oct; 32(2 Suppl 2):S40-7. PubMed ID: 9808142
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Parathyroid growth and regression in experimental uremia.
Taniguchi M; Tokumoto M; Matsuo D; Tsuruya K; Hirakata H; Iida M
Kidney Int; 2006 Feb; 69(3):464-70. PubMed ID: 16395258
[TBL] [Abstract][Full Text] [Related]
9. In vivo regulation of chromogranin A messenger ribonucleic acid in the parathyroid by 1,25-dihydroxyvitamin D: studies in normal rats and in chronic renal insufficiency.
Soliman E; Canaff L; Fox J; Hendy GN
Endocrinology; 1997 Jun; 138(6):2596-600. PubMed ID: 9165053
[TBL] [Abstract][Full Text] [Related]
10. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients.
Mao J; Wang M; Ni L; Gong W; Jiang X; Zhang Q; Zhang M; Wen D; Chen J
Endocrinology; 2021 Jul; 162(7):. PubMed ID: 33912936
[TBL] [Abstract][Full Text] [Related]
11. The calcimimetic R-568 increases vitamin D receptor expression in rat parathyroid glands.
Rodriguez ME; Almaden Y; Cañadillas S; Canalejo A; Siendones E; Lopez I; Aguilera-Tejero E; Martin D; Rodriguez M
Am J Physiol Renal Physiol; 2007 May; 292(5):F1390-5. PubMed ID: 17200160
[TBL] [Abstract][Full Text] [Related]
12. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients.
Fukuda N; Tanaka H; Tominaga Y; Fukagawa M; Kurokawa K; Seino Y
J Clin Invest; 1993 Sep; 92(3):1436-43. PubMed ID: 8397225
[TBL] [Abstract][Full Text] [Related]
13. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation.
Lewin E; Garfia B; Recio FL; Rodriguez M; Olgaard K
J Am Soc Nephrol; 2002 Aug; 13(8):2110-6. PubMed ID: 12138143
[TBL] [Abstract][Full Text] [Related]
14. Direct upregulation of parathyroid calcium-sensing receptor and vitamin D receptor by calcimimetics in uremic rats.
Mendoza FJ; Lopez I; Canalejo R; Almaden Y; Martin D; Aguilera-Tejero E; Rodriguez M
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F605-13. PubMed ID: 19091789
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor and PCNA expression in severe parathyroid hyperplasia of uremic patients.
Wang X; Sun B; Zhou F; Hu J; Yu X; Peng T
Chin Med J (Engl); 2001 Apr; 114(4):410-4. PubMed ID: 11780466
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor agonist VS-105 directly modulates parathyroid hormone expression in human parathyroid cells and in 5/6 nephrectomized rats.
Sawada K; Wu-Wong JR; Chen YW; Wessale JL; Kanai G; Kakuta T; Fukagawa M
J Steroid Biochem Mol Biol; 2017 Mar; 167():48-54. PubMed ID: 27989797
[TBL] [Abstract][Full Text] [Related]
17. Impaired homologous upregulation of vitamin D receptor in rats with chronic renal failure.
Koyama H; Nishizawa Y; Inaba M; Hino M; Prahl JM; DeLuca HF; Morii H
Am J Physiol; 1994 May; 266(5 Pt 2):F706-12. PubMed ID: 8203553
[TBL] [Abstract][Full Text] [Related]
18. Binding of highly concentrated maxacalcitol to the nuclear vitamin D receptors of parathyroid cells.
Shiizaki K; Hayakawa N; Imazeki I; Hatamura I; Okada T; Negi S; Sakaguchi T; Shigematsu T; Akizawa T
Nephrol Dial Transplant; 2007 Apr; 22(4):1078-86. PubMed ID: 17234669
[TBL] [Abstract][Full Text] [Related]
19. 1,25-(OH)2D receptors are decreased in parathyroid glands from chronically uremic dogs.
Brown AJ; Dusso A; Lopez-Hilker S; Lewis-Finch J; Grooms P; Slatopolsky E
Kidney Int; 1989 Jan; 35(1):19-23. PubMed ID: 2540371
[TBL] [Abstract][Full Text] [Related]
20. Molecular and morphological approach of uremia-induced hyperplastic parathyroid gland following direct maxacalcitol injection.
Shiizaki K; Hatamura I; Nakazawa E; Ogura M; Masuda T; Akizawa T; Kusano E
Med Mol Morphol; 2008 Jun; 41(2):76-82. PubMed ID: 18592161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
